# EDGAR Filing Document

**Accession Number:** 0001944901
**File Stem:** 0001944901-25-000004
**Filing Date:** 2025-10
**Character Count:** 9002
**Document Hash:** dd06b45ae74685df5bda06f9084b3e50
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001944901-25-000004.hdr.sgml**: 20251022

**ACCESSION NUMBER**: 0001944901-25-000004

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251020

**FILED AS OF DATE**: 20251022

**DATE AS OF CHANGE**: 20251022

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Donnelly Phil
- **CENTRAL INDEX KEY:** 0001944901

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36682
- **FILM NUMBER:** 251411094

**MAIL ADDRESS:**
- **STREET 1:** 8214 WESTCHESTER DR. SUITE 800
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Veritex Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001501570
- **STANDARD INDUSTRIAL CLASSIFICATION:** STATE COMMERCIAL BANKS [6022]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 270973566
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 8214 WESTCHESTER DRIVE
- **STREET 2:** SUITE 800
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225
- **BUSINESS PHONE:** 972-349-6200

**MAIL ADDRESS:**
- **STREET 1:** 8214 WESTCHESTER DRIVE
- **STREET 2:** SUITE 800
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[x] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Donnelly Phil<br><sub>(Last) (First) (Middle)</sub><br>8214 WESTCHESTER DR. SUITE 800<br><sub>(Street)</sub><br>DALLAS, TX 75225<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_SEVP, General Counsel_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Veritex Holdings, Inc. [ VBTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-10-20 |  | D<sup>(1)</sup> |  | 5842 | D | <sup>(2)</sup> | 0 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(3)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 863 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 863 | <sup>(4)</sup> | 0 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 2406 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 2406 | <sup>(4)</sup> | 0 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 3297 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 3297 | <sup>(4)</sup> | 0 | D |  |
| Performance Stock Units | <sup>(5)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 1307 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 1307 | <sup>(5)</sup> | 0 | D |  |
| Performance Stock Units | <sup>(5)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 1307 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 1307 | <sup>(5)</sup> | 0 | D |  |
| Performance Stock Units | <sup>(5)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 3153 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 3153 | <sup>(5)</sup> | 0 | D |  |
| Performance Stock Units | <sup>(5)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 3153 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 3153 | <sup>(5)</sup> | 0 | D |  |
| Performance Stock Units | <sup>(5)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 2518 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 2518 | <sup>(5)</sup> | 0 | D |  |
| Performance Stock Units | <sup>(5)</sup> | 2025-10-20 |  | D<sup>(1)</sup> |  |  | 2519 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 2519 | <sup>(5)</sup> | 0 | D |  |

---

### Footnotes:

(1) On October 20, 2025, Huntington Bancshares Incorporated (Huntington) acquired the Issuer pursuant to the terms of that certain Agreement and Plan of Merger entered into by and between Huntington and the Issuer, dated as of July 13, 2025 (the Merger Agreement). Pursuant to the terms of the Merger Agreement, the Issuer merged with and into Huntington, with Huntington surviving such merger (the Merger).

(2) Pursuant to the terms of the Merger Agreement, each share of Issuer common stock (other than certain excluded shares) outstanding immediately prior to the effective time of the Merger (the Effective Time) converted into the right to receive 1.95 shares of Huntington common stock (the Merger Consideration).

(3) Each restricted stock unit represents a right to receive at settlement one share of common stock of the Company.

(4) Pursuant to the terms of the Merger Agreement, each RSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (without interest) a number of shares of Huntington common stock equal to the product of (i) the number of shares of Issuer common stock subject to such RSU immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio (as defined below), less any applicable tax withholdings. The ratio of 1.95 shares of Huntington common stock for one share of Issuer common stock is referred to as the Exchange Ratio.

(5) Pursuant to the terms of the Merger Agreement, each performance stock unit (PSU) previously granted by the Issuer outstanding immediately prior to the Effective Time was deemed to vest at target, was canceled and converted into the right to receive (without interest) a number of shares of Huntington common stock equal to the product of (i) the number of shares of Issuer common stock subject to such PSU immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio.

**Signature:** /s/ C. Malcolm Holland, III, by power of attorney  
**Date:** 2025-10-22

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**